Medicare GLP-1 Bridge: What Medicare Beneficiaries Need to Know

If you’ve heard about medications like Wegovy or Zepbound but felt they were too expensive, there’s good news. Starting July 1, 2026, Medicare is introducing a new program that could lower the price of these medications to just $50 per month for eligible beneficiaries.

This program, called the Medicare GLP-1 Bridge, is designed to help people access medications that support weight loss and improve overall health.

What Is This New Program?

The Medicare GLP-1 Bridge is a temporary program that will run from July 1, 2026 through December 31, 2027.  

It allows qualifying Medicare beneficiaries to get certain weight-loss medications, known as GLP-1 drugs, for a flat cost of $50 per month.  

These medications are currently very expensive (often over $1,000 per month), which is why many people have not been able to afford them.  

The Bridge program is designed to change that by lowering your out-of-pocket cost to something more manageable.

What Are GLP-1 Medications?

GLP-1 medications are prescription drugs that help with weight loss and blood sugar control.

They work by helping you feel full longer, reducing appetite, and improving how your body processes food. These medications were originally used for diabetes but are now widely prescribed for weight management.  

Some well-known examples include Wegovy® and Zepbound®.  For many people, these medications can lead to meaningful weight loss and may also reduce the risk of health problems, like heart disease.  

Who Can Qualify?

You may be eligible for this program if:

• You are enrolled in Medicare Part D (or a Medicare Advantage plan with drug coverage)
• Your doctor determines that a GLP-1 medication is appropriate for you
• You meet certain health criteria (such as having obesity or related conditions)
• Your doctor submits a prior authorization request that gets approved

The best first step is to talk with your doctor. They can help determine if this type of medication is right for your health needs.

How Does It Work?

Here’s what you can expect if you’re interested in participating in the Medicare GLP-1 Bridge program:

1. Talk to your doctor about whether a GLP-1 medication is right for you
2. Your doctor will submit a request to Medicare
3. If approved, you can fill your prescription
4. You will pay $50 for a one-month supply

The program is designed to be simple and consistent no matter where you live, with Medicare coordinating the process behind the scenes.

Important Things to Keep in Mind

While this program offers exciting opportunities, there are a few things to understand:

• It’s temporary: The program ends on December 31, 2027
• Not everyone will qualify: You must meet medical and coverage requirements
• Approval is required: Your doctor must submit documentation before coverage is granted
• Talk to your provider: These medications are not right for everyone

Also, because this is a special demonstration program, it works a little differently than regular Medicare drug coverage.

What Should You Do Next?

If you think this program might benefit you:

• Schedule a visit with your doctor to discuss your options
• Review your Medicare prescription drug coverage (Part D or Medicare Advantage)
• Watch for more information from Medicare as the program begins

CMS has said it will continue sharing updates and resources to help beneficiaries understand how to enroll and use the program.

Conclusion

The Medicare GLP-1 Bridge program is a new opportunity to access GLP-1 medications at just $50 per month, for those who qualify.

As always, your doctor is your best resource for deciding what treatments are right for you. If you would like a review of your Medicare policies, please do not hesitate to contact our office to schedule an appointment with your Senior Allies agent (833-801-7999).

‍

Additional information about this program can be found on the CMS website.